E-LIB Suche - Ergebnisse für: Jörger, Markus

1

Pharmacometric modeling of fluoropyrimidines:

Schmulenson, Eduard , 2023

Link: https://nbn-resolving.de..

2

Characteristics and survival of patients with cancer with i..:

Schmitt, Andreas Michael ; Walter, Martin ; Herbrand, Amanda Katherina...
BMJ Open. 12 (2022) 5 - p. e060453 , 2022

Link: https://doi.org/10.1136/..

3

Clinical Implementation of DPYD Pharmacogenetic Testing to ..:

Begré, Ursina B. M. ; Jörger, Markus ; Aebi, Stefan..
Frontiers in Pharmacology. 13 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

4

Keratinocyte differentiation antigen-specific T cells in im..:

Berner, Fiamma ; Niederer, Rebekka ; Luimstra, Jolien J....
OncoImmunology. 10 (2021) 1 - p. , 2021

Link: https://doi.org/10.1080/..

5

Human leukocyte antigen variation is associated with advers..:

Hasan Ali, Omar ; Berner, Fiamma ; Bomze, David...
European Journal of Cancer. 107 (2019) - p. 8-14 , 2019

Link: https://doi.org/10.1016/..

6

Population pharmacokinetics of doxorubicin: establishment o..:

Kontny, Nina E. ; Würthwein, Gudrun ; Joachim, Boos...
Cancer Chemotherapy and Pharmacology. 71 (2013) 3 - p. 749-763 , 2013

Link: https://doi.org/10.1007/..

7

Individual versus standard quality of life assessment in a ..:

Ribi, Karin ; Bernhard, Jürg ; Schuller, Jan C....
Lung Cancer. 61 (2008) 3 - p. 398-404 , 2008

Link: https://doi.org/10.1016/..

8

O-200 Neoadjuvant chemotherapy followed by pleuropneumonect..:

Stahel, Rolf A. ; Weder, Walter ; Ballabeni, Pierluigi...
Lung Cancer. 41 (2003) - p. S59 , 2003

Link: https://doi.org/10.1016/..

9

Impact of Neurorehabilitation on Disability in Patients wit..:

Jörger, Markus ; Beer, Serafin ; Kesselring, Jürg
Neurorehabilitation and Neural Repair. 15 (2001) 1 - p. 15-22 , 2001

Link: https://doi.org/10.1177/..

10

NCMP-23. PEMBROLIZUMAB-ASSOCIATED CD8+ VASCULITIC MONONEURI..:

Baldauf, Michaela ; Monika, Kapauer ; Markus, Jörger...
Neuro-Oncology. 22 (2020) Supplement_2 - p. ii127-ii127 , 2020

Link: https://doi.org/10.1093/..

11

Characteristics and survival of patients with cancer with i..:

Schmitt, Andreas Michael ; Walter, Martin ; Herbrand, Amanda Katherina...
https://boris.unibe.ch/170268/. , 2022

Link: https://boris.unibe.ch/1..

12

Clinical Implementation of DPYD Pharmacogenetic Testing to ..:

Begré, Ursina B M ; Jörger, Markus ; Aebi, Stefan..
https://boris.unibe.ch/170469/. , 2022

Link: https://boris.unibe.ch/1..

13

Clinical Implementation of DPYD Pharmacogenetic Testing to ..:

Begré, Ursina B. M ; Jörger, Markus ; Aebi, Stefan..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159275/. , 2022

Link: http://www.ncbi.nlm.nih...

14

DataSheet1_Clinical Implementation of DPYD Pharmacogenetic ..:

Ursina B. M. Begré ; Markus Jörger ; Stefan Aebi..
doi:10.3389/fphar.2022.885259.s001. , 2022

Link: https://doi.org/10.3389/..

15

Image1_Clinical Implementation of DPYD Pharmacogenetic Test..:

Ursina B. M. Begré ; Markus Jörger ; Stefan Aebi..
doi:10.3389/fphar.2022.885259.s002. , 2022

Link: https://doi.org/10.3389/..